Auris Health raises $220mm in Series E funding round

Auris Health Inc. (formerly Auris Surgical Robotics) raised $220mm through what appears to be its Series E round led by Partner Fund Management. New investors Wellington Management, D1 Capital Partners, and Senator Investment Group were joined by returning backers Mithril Capital, Lux Capital, and Viking Global Investors. The company previously raised $280mm through its D round in August 2017, and has now accumulated over $700mm in venture funding since inception. Proceeds will support commercialization of Auris' Monarch flexible robotic endoscope platform, which is indicated for the prevention and treatment of lung cancer lesions via endoscopy and bronchoscopy procedures. Funds will also support advancement of next-generation robotic interventional technologies.